KCNC1 and depressive symptom measurement: Dysregulation of Kv3.1 channel properties could disrupt axolemma dynamics, affecting neural signaling and potentially causing severe neurological disorders like epilepsy and broad phenotypic spectrum including developmental delay (53), schizophrenia (54), and depression (55).